KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Gains from Sales and Divestitures (2019 - 2021)

Twist Bioscience (TWST) has disclosed Gains from Sales and Divestitures for 3 consecutive years, with $62000.0 as the latest value for Q4 2021.

  • Quarterly Gains from Sales and Divestitures rose 14.81% to $62000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $62000.0 through Dec 2021, up 14.81% year-over-year, with the annual reading at $237000.0 for FY2021, 33.15% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2021 was $62000.0 at Twist Bioscience, down from $237000.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $237000.0 in Q3 2021, with the low at $178.0 in Q2 2021.
  • Average Gains from Sales and Divestitures over 3 years is $97130.9, with a median of $67000.0 recorded in 2021.
  • The sharpest move saw Gains from Sales and Divestitures soared 2125.0% in 2020, then tumbled 99.88% in 2021.
  • Over 3 years, Gains from Sales and Divestitures stood at $8000.0 in 2019, then surged by 575.0% to $54000.0 in 2020, then rose by 14.81% to $62000.0 in 2021.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $62000.0, $237000.0, and $178.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.